Annual EBIT
-$208.13 M
-$60.29 M-40.78%
December 31, 2023
Summary
- As of February 7, 2025, COGT annual earnings before interest & taxes is -$208.13 million, with the most recent change of -$60.29 million (-40.78%) on December 31, 2023.
- During the last 3 years, COGT annual EBIT has fallen by -$172.84 million (-489.79%).
- COGT annual EBIT is now -3057.31% below its all-time high of -$6.59 million, reached on December 31, 2015.
Performance
COGT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$75.41 M
-$11.03 M-17.13%
September 30, 2024
Summary
- As of February 7, 2025, COGT quarterly earnings before interest & taxes is -$75.41 million, with the most recent change of -$11.03 million (-17.13%) on September 30, 2024.
- Over the past year, COGT quarterly EBIT has dropped by -$11.03 million (-17.13%).
- COGT quarterly EBIT is now -3466.70% below its all-time high of $2.24 million, reached on December 31, 2019.
Performance
COGT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$260.43 M
-$15.83 M-6.47%
September 30, 2024
Summary
- As of February 7, 2025, COGT TTM earnings before interest & taxes is -$260.43 million, with the most recent change of -$15.83 million (-6.47%) on September 30, 2024.
- Over the past year, COGT TTM EBIT has dropped by -$15.83 million (-6.47%).
- COGT TTM EBIT is now -4191.20% below its all-time high of -$6.07 million, reached on March 31, 2017.
Performance
COGT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
COGT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.8% | -17.1% | -6.5% |
| 3 y3 years | -489.8% | -280.5% | -324.4% |
| 5 y5 years | -478.1% | -918.7% | -1015.8% |
COGT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -175.5% | at low | -194.1% | at low | -244.7% | at low |
| 5 y | 5-year | -546.8% | at low | -3466.7% | at low | -1106.1% | at low |
| alltime | all time | -3057.3% | at low | -3466.7% | at low | -4191.2% | at low |
Cogent Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$75.41 M(+17.1%) | -$260.43 M(+6.5%) |
| Jun 2024 | - | -$64.39 M(+3.2%) | -$244.60 M(+7.6%) |
| Mar 2024 | - | -$62.40 M(+7.2%) | -$227.30 M(+9.2%) |
| Dec 2023 | -$208.13 M(+40.8%) | -$58.23 M(-2.3%) | -$208.13 M(+7.5%) |
| Sep 2023 | - | -$59.58 M(+26.5%) | -$193.65 M(+13.3%) |
| Jun 2023 | - | -$47.09 M(+8.9%) | -$170.89 M(+7.0%) |
| Mar 2023 | - | -$43.24 M(-1.2%) | -$159.66 M(+8.0%) |
| Dec 2022 | -$147.84 M(+95.7%) | -$43.74 M(+18.8%) | -$147.84 M(+14.0%) |
| Sep 2022 | - | -$36.82 M(+2.7%) | -$129.73 M(+15.1%) |
| Jun 2022 | - | -$35.85 M(+14.1%) | -$112.73 M(+19.7%) |
| Mar 2022 | - | -$31.42 M(+22.5%) | -$94.17 M(+24.6%) |
| Dec 2021 | -$75.55 M(+114.1%) | -$25.64 M(+29.4%) | -$75.55 M(+23.1%) |
| Sep 2021 | - | -$19.82 M(+14.6%) | -$61.37 M(+18.4%) |
| Jun 2021 | - | -$17.29 M(+35.1%) | -$51.84 M(+23.6%) |
| Mar 2021 | - | -$12.80 M(+11.7%) | -$41.95 M(+18.9%) |
| Dec 2020 | -$35.29 M | -$11.46 M(+11.3%) | -$35.29 M(+63.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$10.29 M(+39.0%) | -$21.59 M(-7.5%) |
| Jun 2020 | - | -$7.40 M(+20.6%) | -$23.34 M(-11.9%) |
| Mar 2020 | - | -$6.14 M(-374.2%) | -$26.48 M(-17.7%) |
| Dec 2019 | -$32.18 M(-10.6%) | $2.24 M(-118.6%) | -$32.18 M(-25.9%) |
| Sep 2019 | - | -$12.04 M(+14.2%) | -$43.42 M(+3.5%) |
| Jun 2019 | - | -$10.54 M(-11.0%) | -$41.96 M(+2.7%) |
| Mar 2019 | - | -$11.84 M(+31.5%) | -$40.86 M(+13.5%) |
| Dec 2018 | -$36.01 M(+37.7%) | -$9.00 M(-14.9%) | -$36.01 M(+6.3%) |
| Sep 2018 | - | -$10.58 M(+12.0%) | -$33.88 M(+11.2%) |
| Jun 2018 | - | -$9.44 M(+35.1%) | -$30.48 M(+12.6%) |
| Mar 2018 | - | -$6.99 M(+1.5%) | -$27.07 M(+3.5%) |
| Dec 2017 | -$26.15 M(+37.1%) | -$6.88 M(-4.0%) | -$26.15 M(+35.7%) |
| Sep 2017 | - | -$7.17 M(+18.8%) | -$19.27 M(+59.2%) |
| Jun 2017 | - | -$6.03 M(-0.6%) | -$12.10 M(+99.4%) |
| Mar 2017 | - | -$6.07 M | -$6.07 M |
| Dec 2016 | -$19.07 M(+189.3%) | - | - |
| Dec 2015 | -$6.59 M | - | - |
FAQ
- What is Cogent Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cogent Biosciences?
- What is Cogent Biosciences annual EBIT year-on-year change?
- What is Cogent Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cogent Biosciences?
- What is Cogent Biosciences quarterly EBIT year-on-year change?
- What is Cogent Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cogent Biosciences?
- What is Cogent Biosciences TTM EBIT year-on-year change?
What is Cogent Biosciences annual earnings before interest & taxes?
The current annual EBIT of COGT is -$208.13 M
What is the all time high annual EBIT for Cogent Biosciences?
Cogent Biosciences all-time high annual earnings before interest & taxes is -$6.59 M
What is Cogent Biosciences annual EBIT year-on-year change?
Over the past year, COGT annual earnings before interest & taxes has changed by -$60.29 M (-40.78%)
What is Cogent Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of COGT is -$75.41 M
What is the all time high quarterly EBIT for Cogent Biosciences?
Cogent Biosciences all-time high quarterly earnings before interest & taxes is $2.24 M
What is Cogent Biosciences quarterly EBIT year-on-year change?
Over the past year, COGT quarterly earnings before interest & taxes has changed by -$11.03 M (-17.13%)
What is Cogent Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of COGT is -$260.43 M
What is the all time high TTM EBIT for Cogent Biosciences?
Cogent Biosciences all-time high TTM earnings before interest & taxes is -$6.07 M
What is Cogent Biosciences TTM EBIT year-on-year change?
Over the past year, COGT TTM earnings before interest & taxes has changed by -$15.83 M (-6.47%)